Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Long-Term Investments: 2022-2025

Historic Long-Term Investments for Cellebrite DI (CLBT) over the last 4 years, with Sep 2025 value amounting to $117.1 million.

  • Cellebrite DI's Long-Term Investments rose 203.93% to $117.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $117.1 million, marking a year-over-year increase of 203.93%. This contributed to the annual value of $36.6 million for FY2024, which is 26.83% up from last year.
  • Latest data reveals that Cellebrite DI reported Long-Term Investments of $117.1 million as of Q3 2025, which was down 20.27% from $146.9 million recorded in Q2 2025.
  • Cellebrite DI's Long-Term Investments' 5-year high stood at $146.9 million during Q2 2025, with a 5-year trough of -$112.7 million in Q3 2024.
  • Moreover, its 3-year median value for Long-Term Investments was -$16.4 million (2023), whereas its average is $9.5 million.
  • In the last 5 years, Cellebrite DI's Long-Term Investments slumped by 318.25% in 2024 and then spiked by 306.54% in 2025.
  • Over the past 4 years, Cellebrite DI's Long-Term Investments (Quarterly) stood at $22.1 million in 2022, then spiked by 30.44% to $28.9 million in 2023, then grew by 26.83% to $36.6 million in 2024, then spiked by 203.93% to $117.1 million in 2025.
  • Its last three reported values are $117.1 million in Q3 2025, $146.9 million for Q2 2025, and $141.3 million during Q1 2025.